This article reviews the use of oral micronized progesterone as a preferred alternative to synthetic progestins in hormone replacement therapy for postmenopausal women. It highlights that while unopposed estrogen therapy increases the risk of endometrial hyperplasia and cancer, the addition of progesterone effectively mitigates this risk. Micronized progesterone, with comparable
